|
705 Pharmacists should
support GPs, says new report As a profession,
pharmacists need to recognise the value of, and constructively support,
general medical practice, according to a policy report from the School
of Pharmacy, University of London, published this week
PJ 2008;280:705
Full Text
705 Churchill tribute to pharmacist
discovered A letter from Winston Churchill paying tribute to the achievements of Edward Harrison, the pharmacist credited with inventing the gas mask that saved hundreds of thousands of soldiers’ lives in the 1914–18 war, has recently been discovered, it was disclosed this week
PJ 2008;280:705
Full Text
705 Think tank criticises health minister’s
polyclinics plan Government plans for a network of polyclinics or super-surgeries in England — at the heart of the NHS review by health minister Lord Darzi — faced a setback last week following an analysis by the influential think tank the King’s Fund
PJ 2008;280:705
Full Text
705 New system will measure PCT commissioning
performance The Government’s vision of world class commissioning in England came closer last week with the launch of an assurance system that will measure primary care trust commissioning performance in the key areas of health outcomes, competencies and governance
PJ 2008;280:705
Full Text
706 Pharmacists found to make
poor ethical decisions Community pharmacists have
been found wanting when it comes to making ethical decisions at work, according
to research published
PJ 2008;280:706
Full Text
706 School of Pharmacy and FIP join in global
project to develop pharmacy A school of pharmacy
is hoping to become a global leader in the development of pharmacy and its influence
on public health in a unique partnership with the International Pharmaceutical
Federation (FIP)
PJ 2008;280:706
Full Text
706 Unison and RCN vote to accept three-year
pay deal for NHS staff Health union Unison and
the Royal College of Nursing have both voted to accept a three-year pay deal
from the Department of Health with an overall increase of almost 8 per cent for
NHS workers
PJ 2008;280:706
Full Text
707 Avoid contaminated Clexane
for pregnant women, says MHRA Batches of Clexane
(enoxaparin sodium; Sanofi-Aventis) contaminated with small amounts of over-sulphated
chondroitin sulphate (OSCS) should not be used for pregnant women, the Medicines
and Healthcare products Regulatory Agency advised last week
PJ 2008;280:707
Full Text
707 MTX melanoma risk Patients
with rheumatoid arthritis (RA) who are treated with methotrexate are at increased
risk of melanoma and other malignancies, a new review of data suggests
PJ 2008;280:707
Full Text
707 GI ulceration with nicorandil highlighted
in latest Drug Safety Update Risk of gastrointestinal ulceration with nicorandil (Ikorel) is highlighted in this June 2008’s issue of Drug
Safety Update, published by the Medicines and Healthcare products Regulatory Agency
PJ 2008;280:707
Full Text
708 NHS Scotland has access
to seven more medicines Dabigatran etexilate (Pradaxa)
has been accepted for use within NHS Scotland for the primary prevention of venous
thromboembolic events. The latest round of appraisals by the Scottish Medicines
Consortium sees it accept seven medicines and reject eight
PJ 2008;280:708
Full Text
708 Scottish contract announcement expected Community pharmacists in Scotland can expect to hear the details of this year’s remuneration package, including an announcement on new services, at the end of June 2008
PJ 2008;280:708
Full Text
708 CPS supports drugs strategy Community Pharmacy Scotland pledged this week to help develop pharmacy services that will support the Scottish Government’s new national drugs strategy that focuses on recovery from addiction
PJ 2008;280:708
Full Text
708 Dispensing consultation end Pharmacists
wishing to comment on whether professional guidelines should be changed to allow
removal of medicines from blister or foil packs ahead of dispensing and the dispensing
of out-of-date or returned medicines in the case of an influenza pandemic should
make their views known by 20 June 2008
PJ 2008;280:708
Full Text
708 Pfizer Award for 2008 This year’s Pfizer Award, recognising achievement among preregistration trainee pharmacists in Scotland, was won by David Chartres, preregistration trainee at Ninewells Hospital in Dundee
PJ 2008;280:708
Full Text
709 Debate rumbles on over
intensive glycaemic control No definitive answer
to the therapeutic problem of glycaemic control in patients with type 2 diabetes
at high risk of cardiovascular events has been provided by the results of two
recently completed multicentre clinical trials, according to the author of an
editorial published
PJ 2008;280:709
Full Text
709 Glitazone may delay retinopathy Rosiglitazone
may delay the onset of proliferative diabetic retinopathy, say researchers. It
may also be associated with less loss of visual acuity
PJ 2008;280:709
Full Text
709 Sirolimus linked to diabetes risk Sirolimus
is associated with an increased risk of new-onset diabetes in kidney transplant
patients, researchers report
PJ 2008;280:709
Full Text
710 Tailor care plan according to disease’s impact on patients’ day-to-day lives, says COPD expert Community pharmacists should place greater emphasis on the impact of chronic obstructive pulmonary disease (COPD) on patients’ everyday lives when tailoring care, according to an expert in the condition
PJ 2008;280:710
Full Text
710 Plans to tackle inequalities should maximise
pharmacy contribution Plans to tackle health inequalities
should maximise the contribution that pharmacists and their teams can make, the
Royal Pharmaceutical Society has said in response to Government proposals on
the issue
PJ 2008;280:710
Full Text
710 Swiss move for Alliance Boots Alliance
Boots has moved the headquarters of the group holding company from Gibraltar
to Switzerland
PJ 2008;280:710
Full Text
710 New stoma appliance provision proposals Revised proposals on the arrangements for provision of stoma and urology appliances — and related services — in primary care, under Part IX of the Drug Tariff, have been published by the Department of Health
PJ 2008;280:710
Full Text
710 Duke visits London pharmacy The
Duke of Edinburgh visited Boss Pharmacy in Clapham, London, earlier this month
where he heard about the delivery of community pharmacy services, including those
commissioned by the local primary care trust
PJ 2008;280:710
Full Text
711 Antispasmodic launched
for overactive bladder syndrome Patients with overactive bladder syndrome could benefit from a new urinary antispasmodic — fesoterodine fumarate — now available from Pfizer
PJ 2008;280:711
Full Text
711 Incontinence product first for Boots Centre
for Innovation A device designed to control urinary
stress incontinence has been launched by the Boots Centre for Innovation
PJ 2008;280:711
Full Text
711 Advertising breach A pharmacy group in the Midlands has been judged to be in breach of advertising regulations following a complaint that its website was advertising an unlicensed homoeopathic injection as an anticancer treatment
PJ 2008;280:711
Full Text
711 Funding for champions Funding for community pharmacy practitioner champions in Scotland will continue during 2008–09, the Scottish Government has announced
PJ 2008;280:711
Full Text
711 Oxygen supplies The
current shortage of DD oxygen cylinders (integral head portable cylinders) is
expected to start improving in June 2008
PJ 2008;280:711
Full Text
712 Avoid antioxidant supplements
during chemo- and radiotherapy Use of supplemental
antioxidants during chemotherapy and radiotherapy should be avoided until they
are shown to be safe, according to the authors of a commentary published. The
combined treatment approach should be discouraged because of the possibility
of tumour protection and reduced survival, they say
PJ 2008;280:712
Full Text
712 Mobile telephones help cancer patients manage
side effects Teenagers with cancer are using mobile
telephones to monitor the side effects of their chemotherapy treatment at home
in an initiative that may be rolled out across the UK
PJ 2008;280:712
Full Text
712 Cyclophosphamide could have role in multiple
sclerosis therapy Treatment with cyclophosphamide,
without bone marrow transplantation, appears to reduce disease activity and disability
in patients with aggressive relapsing-remitting multiple sclerosis
PJ 2008;280:712
Full Text
712 MHRA publishes its plans to tighten rules
on reporting safety data from clinical trials Proposals
to amend UK legislation to state explicitly that marketing authorisation holders
should report safety information from clinical trials outside the licensed indication
and information arising from third countries, and to provide a timescale for
reporting such information, have been put forward by the Medicines and Healthcare
products Regulatory Agency
PJ 2008;280:712
Full Text
712 Aliskiren provides renoprotective effect Aliskiren
appears to have a renoprotective effect independent of its blood pressure lowering
effect in patients with type 2 diabetes and nephropathy who are receiving losartan
(at the maximum recommended renoprotective dose) and optimal antihypertensive
therapy
PJ 2008;280:712
Full Text |
The
Pharmaceutical Journal